Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Mallinckrodt
Merck
Moodys
McKinsey

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Suppliers and packages for biologic ingredient: durvalumab

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Suppliers and packages for biologic ingredient: durvalumab

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities
Applicant Tradename Biologic Ingredient Dosage BLA NDA/ANDA Supplier Package Code Package
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 BLA AstraZeneca Pharmaceuticals LP 0310-4500-12 1 VIAL in 1 CARTON (0310-4500-12) > 2.4 mL in 1 VIAL
Astrazeneca Uk Ltd IMFINZI durvalumab INJECTABLE;INJECTION 761069 BLA AstraZeneca Pharmaceuticals LP 0310-4611-50 1 VIAL in 1 CARTON (0310-4611-50) > 10 mL in 1 VIAL
>Applicant >Tradename >Biologic Ingredient >Dosage >BLA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Express Scripts
Dow
McKesson